SCHEMBL7469713

SCHEMBL7469713

Cc1c(C(=O)C(C)C)c2ccc(C(=O)O)cc2n1Cc1ccccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.52
SLC22A12 Q96S37 2/20 0.47
ALOX5AP P20292 4/20 0.46
PTPN11 Q06124 1/20 0.44
TP53 P04637 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
PLA2G2A P14555 1/20 0.43
CCR2 P41597 1/20 0.42
PPARG P37231 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
PTGES O14684 1/20 0.42
ALOX5 P09917 1/20 0.42
LTC4S Q16873 1/20 0.42
DPP4 P27487 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7422326 0.90 L3MBTL1 (0.51) L3MBTL1ALOX5APTP53RXFP1PLA2G2A
SCHEMBL7414196 0.89 L3MBTL1 (0.65) L3MBTL1SLC22A12ALOX5APPTPN11TP53
SCHEMBL7471087 0.89 L3MBTL1 (0.49) L3MBTL1TP53PLA2G2APPARGALDH1A1
SCHEMBL7428819 0.87 ALOX5AP (0.47) L3MBTL1SLC22A12ALOX5APPTPN11TP53
SCHEMBL7419060 0.87 L3MBTL1 (0.52) L3MBTL1SLC22A12ALOX5APPTPN11TP53
SCHEMBL7418727 0.86 ALOX5AP (0.53) L3MBTL1SLC22A12ALOX5APPTPN11CCR2
SCHEMBL7427533 0.85 ALOX5AP (0.46) L3MBTL1SLC22A12ALOX5APPTPN11TP53
SCHEMBL7472045 0.85 ALOX5AP (0.46) L3MBTL1SLC22A12ALOX5APPTPN11TP53
SCHEMBL7415958 0.85 ALOX5AP (0.43) SLC22A12ALOX5APPTPN11TP53RXFP1
SCHEMBL7475969 0.85 ALOX5AP (0.43) L3MBTL1SLC22A12ALOX5APPTPN11TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed